Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Filings indexed 7,016 across all filing types
Latest filing 2025-11-21 Legal Proceedings Report
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
Initiation of litigation against AnaptysBio Inc
Legal Proceedings Report Classification · 100% confidence The document is an official announcement from GSK PLC regarding the initiation of litigation against AnaptysBio, Inc. by its subsidiary, TESARO. It details the nature of the legal dispute, the specific court involved, and the potential impact on license agreements. Since this document reports on significant legal proceedings and does not fit into financial reporting or other specific categories, it is classified as a Legal Proceedings Report.
2025-11-21 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from GSK plc regarding the purchase of its own shares (share buyback) on the London Stock Exchange and other venues. It includes specific details such as the date of purchase, the number of shares, price ranges, and the resulting impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-11-21 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-11-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from GSK plc regarding the purchase of its own shares as part of an existing buyback program. It includes specific details such as the date of purchase, the number of shares acquired, price ranges, and a detailed schedule of individual trades. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS).
2025-11-20 English
TRANSFER OF TREASURY SHARES
Regulatory Filings
2025-11-19 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-11-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.